Stocks and Investing
Stocks and Investing
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Luca Issi Maintained (BEAM) at Hold with Increased Target to $35 on, Feb 28th, 2024
Luca Issi of RBC Capital, Maintained "Beam Therapeutics Inc." (BEAM) at Hold with Increased Target from $27 to $35 on, Feb 28th, 2024.
Luca has made no other calls on BEAM in the last 4 months.
There are 3 other peers that have a rating on BEAM. Out of the 3 peers that are also analyzing BEAM, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Greg Harrison of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $35 on, Friday, December 15th, 2023
- Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $30 on, Friday, December 8th, 2023
This is the rating of the analyst that currently disagrees with Luca
- Eric Joseph of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $40 on, Monday, January 29th, 2024
Contributing Sources